Literature DB >> 18626256

Advances in minimally invasive facial rejuvenation.

Fred G Fedok1.   

Abstract

PURPOSE OF REVIEW: Current cosmetic surgical practice for facial rejuvenation has undergone a significant change due to the introduction of technologies to improve the age-associated changes of the face. The most widely adopted methods of minimally invasive facial rejuvenation include the use of neuromuscular blocking agents and injectable fillers. The topic of minimally invasive procedures might include a variety of subjects including nutritional and hormonal modulation, light-based and laser-based therapies, minimal incision surgical procedures, as well as the use of botulinum toxin and fillers. The focus of this study will be on the minimally invasive facial rejuvenation efforts achieved by injection techniques. RECENT
FINDINGS: Botulinum A neurotoxin has been shown to be effective in the reduction of hyperfunctional lines in the upper and lower face. Anatomic areas that have been found to benefit include the glabella, the forehead, the periorbital area, lips, and the platysma muscle. The more recently introduced hyaluronic acid and other injectable fillers are receiving increasing usage. These temporary fillers have been found to improve creases and wrinkles, augment deep nasolabial folds, augment thin lips, and improve hollowing in the periorbital and other depressions and deformities.
SUMMARY: There has been a significant paradigm shift in the field of rejuvenation surgery. Injectable minimally invasive methods have been offered to remedy age-related and other acquired deformities of the head and neck region. These methods have provided temporary correction of undesirable characteristic that were traditionally approached with more invasive surgically oriented modalities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626256     DOI: 10.1097/MOO.0b013e3283031c7d

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  8 in total

1.  Venous Thromboembolism Prophylaxis in Plastic Surgery Patients Undergoing Facelift.

Authors:  Rohun Gupta; Jithin John; Monik Gupta; Kenneth Shaheen
Journal:  Aesthet Surg J Open Forum       Date:  2022-04-12

2.  Mid-face reshaping using threads with bidirectional convergent barbs: A retrospective study.

Authors:  Adriano Santorelli; Fabio Cerullo; Pierfrancesco Cirillo; Maurizio Cavallini; Stefano Avvedimento
Journal:  J Cosmet Dermatol       Date:  2021-04-05       Impact factor: 2.189

Review 3.  Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer.

Authors:  Suniti Misra; Vincent C Hascall; Roger R Markwald; Shibnath Ghatak
Journal:  Front Immunol       Date:  2015-05-06       Impact factor: 7.561

4.  Short-term Treatment Outcomes of Facial Rejuvenation Using the Mint Lift Fine.

Authors:  Hyoung-Jin Moon; Dooyeol Chang; Won Lee
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-29

5.  Proposed Treatment Protocols for Facial Rejuvenation Using a Novel Absorbable Polydioxanone Monofilament Threadlift in Koreans: Empirical Perspectives of Aesthetic Physicians and Surgeons.

Authors:  Doo-Yeoul Chang; Hyoung-Moon Kim; Tae Hwan Ahn; Sang Bong Lee; Hyoung-Jin Moon
Journal:  Aesthet Surg J Open Forum       Date:  2020-11-13

6.  Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines.

Authors:  Welf Prager
Journal:  Clin Pharmacol       Date:  2013-03-12

7.  Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study.

Authors:  Thomas Rappl; Daryousch Parvizi; Herwig Friedl; Maria Wiedner; Simone May; Bettina Kranzelbinder; Paul Wurzer; Bengt Hellbom
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-09-24

8.  Majocchi's granuloma caused by Trichophyton rubrum after facial injection with hyaluronic acid: A case report.

Authors:  Jie Liu; Wen-Qiang Xin; Lan-Ting Liu; Chao-Feng Chen; Lin Wu; Xiao-Ping Hu
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.